Cochrane: The aim of this Cochrane Review was to determine whether cataract
surgery is safe and improves vision in eyes with age-related macular
degeneration (AMD) compared with no surgery. Cochrane researchers
collected and analyzed all relevant studies to answer this question and
included two studies. Although data from two small studies suggest that surgery to
remove cataracts in eyes with AMD may improve vision without worsening
of AMD, it is not possible to draw reliable conclusions from the
available data at this time. Physicians must decide whether to recommend cataract surgery to their AMD patients based on clinical judgment until larger studies have been conducted and their findings published.
Only good, independent and reliable information about health from experts.
Showing posts with label Age-related macular degeneration. Show all posts
Showing posts with label Age-related macular degeneration. Show all posts
Thursday, March 2, 2017
Wednesday, December 21, 2016
will I damage my eyes if I don’t wear sunglasses?
TheConversation: The iconic “Slip Slop Slap”
campaign was launched in Australia in 1981. Sid the Seagull encouraged
people to slip on a shirt, slop on sunscreen and slap on a hat to
minimise ultraviolet (UV) radiation exposure and reduce the risk of
sunburn and skin cancer. In 2007, the slogan was updated to “Slip Slop Slap Seek Slide”.
So now it includes seeking shade and sliding on sunglasses to further
reduce the risk of UV-related damage. This emphasises the importance of
protecting eyes – and the skin around them – from UV radiation.
Wednesday, April 1, 2015
Nanobubbles: groundbreaking technology to deliver lower doses of drugs to tissues
Queensland: Bubbles invisible to the naked eye could provide the next
breakthrough in treating heart and eye problems – and present an
alternate treatment for cancer and cellulite as well. University of Queensland pharmacy researcher Dr Harendra Parekh
is confident his team’s nanobubble technology can be applied across a
number of diseases, limiting highly toxic or expensive medicines.
Tuesday, February 17, 2015
FDA approves Lucentis to treat diabetic retinopathy in patients with diabetic macular edema
FDA. US: The U.S. Food and Drug Administration today expanded the approved use
for Lucentis (ranibizumab injection) 0.3 mg to treat diabetic
retinopathy (DR) in patients with diabetic macular edema (DME).
Can statins delay the onset and progression of age-related macular degeneration?
Cochrane: What are the effects of statins on delaying the onset and progression of age-related macular degeneration (AMD)?
Thursday, February 5, 2015
Complex incentives drive macular degeneration prescription decisions, study finds
Stanford University. US: Two drugs that treat macular degeneration are practically interchangeable — except for the price.
Tuesday, January 20, 2015
Major cause of blindness linked to calcium deposits in the eye
University College London. UK: Microscopic spheres of calcium phosphate have been linked to the
development of age-related macular degeneration (AMD), a major cause of
blindness, by UCL-led research.
Monday, February 25, 2013
Age-related macular degeneration (AMD) Overview
Source: Plos Medicine. 2013.
The third leading global cause of blindness (after cataracts and glaucoma) is age-related macular degeneration (AMD).
This group of conditions is characterized by lesions in the macular (central) region of the retina, the tissue at the back of the eye that converts light into electrical messages and sends them to the brain.
AMD, which affects older people, destroys the sharp central vision that is needed for reading or driving, leaving only dim, blurred images or a black hole at the center of vision.
AMD can be diagnosed by examining digital photographs of the retina or by examining the retina directly using a special magnifying lens (slit lamp biomicroscopy).
There is no cure for AMD, although injections into the eye of certain drugs, such as bevacizumab, that block the activity of vascular endothelial growth factor can slow the rate of vision loss caused by some forms of AMD.
The third leading global cause of blindness (after cataracts and glaucoma) is age-related macular degeneration (AMD).
This group of conditions is characterized by lesions in the macular (central) region of the retina, the tissue at the back of the eye that converts light into electrical messages and sends them to the brain.
AMD, which affects older people, destroys the sharp central vision that is needed for reading or driving, leaving only dim, blurred images or a black hole at the center of vision.
AMD can be diagnosed by examining digital photographs of the retina or by examining the retina directly using a special magnifying lens (slit lamp biomicroscopy).
There is no cure for AMD, although injections into the eye of certain drugs, such as bevacizumab, that block the activity of vascular endothelial growth factor can slow the rate of vision loss caused by some forms of AMD.
Subscribe to:
Posts (Atom)
